Possible association between HPV16 E7 protein level and cytokeratin 19

International Journal of Cancer

Volumn 111, Issue 5, 2004, Pages 795-797

  Favia, Gianfranco ^a   Kanduc, Darja ^a   Muzio, Lorenzo Lo ^b   Lucchese, Alberta ^a   Serpico, Rosario ^a  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

CK19; CK7; HPV16 E7 mRNA; Squamous cell carcinoma; Translational regulation

Indexed keywords

CYTOKERATIN 19; CYTOKERATIN 7; MESSENGER RNA; ONCOPROTEIN; PROTEIN E7; VIRUS PROTEIN;

ARTICLE; CELL IMMORTALIZATION; EPITHELIUM; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; KERATINOCYTE; LIFE CYCLE; PRIORITY JOURNAL; PROTEIN CONTENT; SQUAMOUS CELL CARCINOMA; TISSUE DIFFERENTIATION; TRANSLATION REGULATION; VIRUS CELL INTERACTION; VIRUS GENE; VIRUS GENOME; VIRUS REPLICATION; WART VIRUS;

CARCINOMA, SQUAMOUS CELL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KERATIN-7; KERATINOCYTES; KERATINS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; RNA, MESSENGER; TRANSCRIPTION FACTORS; UTERINE CERVICAL NEOPLASMS; ZINC FINGERS;

EID: 4043145072     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20343     Document Type: Article

References (19)

1. zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 2000;92:690-8.
2. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002;2:342-50.
3. Miller CS, Johnstone BM. Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982-1997. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;91:622-35.
4. Ritchie JM, Smith EM, Summersgill KF, Hoffman HT, Wang D, Klussmann JP, Turek LP, Haugen TH. Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer 2003;104:336-44.
5. Zehbe I, Ciccolini F, Dell'Orco M, De Pasquale C, Zaccaro F, Albarani V, Marchini A, Kanduc D, Tommasino M. E7 protein of human papillomaviruses and its interaction with cellular pathways. In: Bannasch P, Kanduc D, Papa S, Tager JM. Cell growth and oncogenesis. Basel: Birkhäuser Verlag, 1998. 97-107.
6. De Pasquale C, Kanduc D. Modulation of HPV16 E7 translation by tRNAs in eukaryotic cell-free translation systems. Biochem Mol Biol Intern 1998;45:1005-9.
7. Kanduc D. Translational regulation of human papillomavirus type 16 E7 mRNA by the peptide SEQIKA, shared by rabbit alphal-globin and human cytokeratin 7. J Virol 2002;76:7040-8.
8. Ramaekers F, van Niekerk C, Poels L, Poels L, Schaafsma E, Huijsmans A, Robben H, Schaart G, Vooijs P. Use of monoclonal antibodies to keratin 7 in the differential diagnosis of adenocarcinomas. Am J Pathol 1990;136:641-55.
9. Schon M, Benwood J, O'Connell-Willstaedt T, Rheinwald JG. Human sweat gland myoepithelial cells express a unique set of cytokeratins and reveal the potential for alternative epithelial and mesenchymal differentiation states in culture. J Cell Sci 1999;112:1925-36.
10. Machado de Sousa SO, Soares de Araujo N, Correa L, Pires Soubhia AM, Cavalcanti de Araujo V. Immunohistochemical aspects of basal cell adenoma and canalicular adenoma of salivary glands. Oral Oncol 2001;37:365-8.
11. Kozuka T, Aoki Y, Nakagawa K, Ohtomo K, Yoshikawa H, Matsumoto K, Yoshiike K, Kanda T. Enhancer-promoter activity of human papillomavirus type 16 long control regions isolated from cell lines SiHa and CaSki and cervical cancer biopsies. Jpn J Cancer Res 2000;91:271-9.
12. Baker CC, Phelps WC, Lindgren V, Braun MJ, Gonda MA, Howley PM. Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J Virol 1987;61: 962-71.
13. Bonfrer JM, Gaarenstroom KN, Korse CM, Van Bunningen BN, Kenemans P. Cyfra 21-1 in monitoring cervical cancer: a comparison with tissue polypeptide antigen and squamous cell carcinoma antigen. Anticancer Res 1997;17:2329-34.
14. Coltrera MD, Zarbo RJ, Sakr WA, Gown AM. Markers for dysplasia of the upper aerodigestive tract. Suprabasal expression of PCNA, p53, and CK19 in alcohol-fixed, embedded tissue. Am J Pathol 1992;141: 817-25.
15. Tsubochi H, Suzuki T, Suzuki S, Ohashi Y, Ishibashi S, Moriya T, Fujimura S, Sasano H. Immunohistochemical study of basaloid squamous cell carcinoma, adenoid cysticand mucoepidermoid carcinoma in the upper aerodigestive tract. Anticancer Res 2000;20:1205-11.
16. Bonfrer JM, Gaarenstroom KN, Kenter GG, Korse CM, Hart AA, Gallee MP, Helmerhorst TJ, Kenemans P. Prognostic significance of serum fragments of cytokeratin 19 measured by Cyfra 21-1 in cervical cancer. Gynecol Oncol 1994;55:371-5.
17. Nasu K, Etoh Y, Yoshimatsu J, Matsu T, Narahara H, Miyakawa I. Serum levels of cytokeratin 19 fragments in cervical cancer. Gynecol Obstet Invest 1996;42:267-70.
18. Nair SA, Nair MB, Jayaprakash PG, Rajalekshmy TN, Nair MK, Pillai MR. Increased expression of cytokeratins 14, 18 and 19 correlates with tumor progression in the uterine cervix. Pathobiology 1997;65:100-7.
19. Molès J-P, Schiller JT, Tesniere A, Leigh IM, Guilhou J-J, Basset-Séguin N. Analysis of HPV16 E6 and mutant p53-transfected keratinocytes in reconstituted epidermis suggests that wild-type p53 inhibits cytokeratin 19 expression. J Cell Sci 1994;107:435-41.